Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,74%
1 094,84
+18,71
+1,74%
—1 076,131 079,891 100,771 079,89——
SIXC
Communications
SIXC
Communications
SIXC
-0,42%
604,21
-2,53
-0,42%
—606,74606,74607,90602,03——
SIXE
Energy
SIXE
Energy
SIXE
+0,07%
1 249,71
+0,89
+0,07%
—1 248,821 246,371 256,421 239,08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,86%
1 739,26
+14,90
+0,86%
—1 724,361 733,021 745,751 727,76——
SIXM
Financials
SIXM
Financials
SIXM
+0,01%
635,63
+0,040
+0,01%
—635,59635,08637,96633,31——
SIXR
Staples
SIXR
Staples
SIXR
+0,61%
848,32
+5,17
+0,61%
—843,15842,50852,77840,85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,22%
216,76
+0,47
+0,22%
—216,29216,29217,30215,24——
SIXT
Technology
SIXT
Technology
SIXT
+2,20%
3 335,14
+71,73
+2,20%
—3 263,413 296,253 343,663 295,42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,01%
939,34
+0,10
+0,01%
—939,24941,57948,11939,11——
SIXV
Health care
SIXV
Health care
SIXV
+0,38%
1 468,17
+5,61
+0,38%
—1 462,561 465,031 471,561 459,66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,28%
2 387,09
+6,69
+0,28%
—2 380,402 394,922 412,132 386,82——
BCRX:NASDAQ
BioCryst Pharmaceuticals Inc
9,03 $
-1,85%
(-0,17) 1D
9,00 $
-0,35% (-0,031)
After hours
Closed: 5 մյս, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCRX...
Open
9,22 $
High
9,30 $
Low
8,94 $
Mkt. cap
2,29 մլրդ
Avg. vol.
4,65 մլն
Volume
3,75 մլն
P/E ratio
7,48
52-wk high
11,31 $
52-wk low
6,00 $
EPS
1,21 $
Beta
0,57
Shares outstanding
254,11 մլն
No. of employees
435
News stories
From sources across the web
Profile
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
About BioCryst Pharmaceuticals Inc
CEOJon P. Stonehouse
Employees435
Founded1986
HeadquartersԴարեմ, Հյուսիսային Կարոլինա, Միացյալ Նահանգներ
Sector-
Websitebiocryst.com
Last report
26 փտվ, 2026 թ.
Fiscal Period
Q4 2025
Normalized EPS / Estimate
0,21/ (0,07 est.)USD
+197,57%beat
Revenue / Estimate
406,56 մլն/ (151,32 մլն est.)USD
+168,67%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
145,53 մլն
163,35 մլն
159,40 մլն
406,56 մլն
Cost of goods sold
41,84 մլն
46,18 մլն
46,79 մլն
48,35 մլն
Cost of revenue
41,84 մլն
46,18 մլն
46,79 մլն
48,35 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82,47 մլն
87,38 մլն
83,01 մլն
91,51 մլն
Operating expense
82,47 մլն
87,38 մլն
83,01 մլն
91,51 մլն
Total operating expenses
124,31 մլն
133,57 մլն
129,80 մլն
139,86 մլն
Operating income
21,23 մլն
29,79 մլն
29,59 մլն
266,70 մլն
Other non operating income
-
-
2,67 մլն
5,86 մլն
EBT including unusual items
758,00 հզր
6,49 մլն
12,13 մլն
248,02 մլն
EBT excluding unusual items
758,00 հզր
10,66 մլն
14,87 մլն
261,19 մլն
Income tax expense
726,00 հզր
1,40 մլն
-769,00 հզր
2,17 մլն
Effective tax rate
95,78%
21,60%
-6,34%
0,88%
Other operating expenses
-
-
-
-
Net income
32,00 հզր
5,08 մլն
12,90 մլն
245,84 մլն
Net profit margin
0,02%
3,11%
8,09%
60,47%
Earnings per share
-
0,04
0,16
0,21
Interest and investment income
3,02 մլն
2,52 մլն
2,24 մլն
2,89 մլն
Interest expense
-23,49 մլն
-21,58 մլն
-19,66 մլն
-14,14 մլն
Net interest expenses
-20,47 մլն
-19,07 մլն
-17,42 մլն
-11,24 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
21,56 մլն
30,12 մլն
31,56 մլն
267,55 մլն
Gain or loss from assets sale
-
-
-550,00 հզր
-3,57 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer